Prevalence of chronic obstructive pulmonary disease and risk factors in São Paulo, Brazil, 2008-2009;Doença pulmonar obstrutiva crônica e fatores associados em São Paulo, SP, 2008-2009

Revista de Saude Publica

Volumn 45, Issue 5, 2011, Pages 887-896

  de Sousa, Clóvis Arlindo ^a   César, Chester Luiz Galvão ^a   Barros, Marilisa Berti de Azevedo ^b   Carandina, Luana ^c   Goldbaum, Moisés ^a   Pereira, Júlio Cesar Rodrigues ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cross sectional studies; Life style; Pulmonary disease, chronic obstructive, epidemiology; Risk factors

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR; SEX RATIO; SMOKING; SOCIOECONOMICS; TIME;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 83455180076     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102011005000051     Document Type: Article

References (24)

1. Brown DW, Croft JB, Greenlund KJ, Giles WH. Trends in hospitalization with chronic obstructive pulmonary disease - United States, 1990-2005. COPD. 2010;7(1):59-62. DOI:10.3109/15412550903499548
2. Consenso Brasileiro sobre Doenca Pulmonar Obstrutiva Crônica II - DPOC. J Bras Pneumol. 2004;30(Supl 5):S1-42.
3. Das UN. Anti-inflammatory nature of exercise. Nutrition. 2004;20(3):323-6. DOI:10.1016/j.nut.2003.11.017
4. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956-62. DOI:10.1136/thx.2009.128082
5. Fiedman M, Hilleman DE. Economic burden of chronic obstrutive pulmonary disease: impact of new treatment options. Pharmacoeconomics. 2001;19(3):245-54.
6. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645-8. DOI:10.1136/bmj.1.6077.1645
7. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity modifies smokingrelated lung function decline and reduces risk of chronic obstructive pulmonary disease: a populationbased cohort study. Am J Respir Crit Care Med. 2007;175(5):458-63. DOI:10.1164/rccm.200607-896OC
8. Gosker HR, Wouters EFM, van der Vusse GJ, Schols AMWJ. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr. 2000;71(5):1033-47.
9. Hallberg J, Dominicus A, Eriksson UK, Gerhardsoon de Verdier M, Pedersen NL, Dahlbäck M, et al. Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Respir Crit Care Med. 2008;177(5):486-90. DOI:10.1164/rccm.200704-565OC
10. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684-92. DOI:10.1378/chest.123.5.1684
11. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523-32. DOI:10.1183/09031936.06.00124605
12. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1081-93. DOI:10.1161/CIRCULATIONAHA.107.185649
13. Hirayama F, Lee AH, Hiramatsu T. Life-long physical activity involvement reduces the risk of chronic obstructive pulmonary disease: a case-control study in Japan. J Phys Act Health. 2010;7(5):622-6.
14. Joos L, Paré PD, Sandford AJ. Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly. 2002;132(3-4):27-37. DOI:2002/03/smw-09752
15. Laurell CC, Eriksson S. The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest. 1963;15(2):132-40. DOI:10.1080/00365516309051324
16. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935-9. DOI:10.1136/thx.2006.062802
17. Menezes AM, Victora CG, Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax. 1994;49(12):1217-21. DOI:10.1136/thx.49.12.1217
18. Menezes AMB, Jardim JR, Perez-Padilla R, Camelier A, Rosa F, Nascimento O, et al. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. Cad Saude Publica. 2005;21(5):1565-73. DOI:10.1590/S0102-311X2005000500030
19. Menezes AMB, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875-81. DOI:10.1016/S0140-6736(05)67632-5
20. Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest. 2003;123(3):784-91. DOI:10.1378/chest.123.3.784
21. Mullerová H, Wedzicha J, Soriano JB, Vestbo J. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med. 2004;98(1):78-83. DOI:10.1016/j.rmed.2003.08.009
22. O'Donnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD. 2007;4(3):225-36. DOI:10.1080/15412550701480455
23. Passowicz-Muszyńska E, Gostkowska-Malec A, Jankowska R, Piesiak P. Chronic obstructive pulmonary disease and cardiovascular diseases. Pneumonol Alergol Pol. 2010;78(1):28-32.
24. Sousa MH, Silva NN. Estimativas obtidas de um levantamento complexo. Rev Saude Publica. 2003;37(5):622-70. DOI:10.1590/S0034-89102003000500018